Brookline Capital Management Predicts QNCX Q2 Earnings
Quince Therapeutics, Inc. (NASDAQ:QNCX – Free Report) – Brookline Capital Management lowered their Q2 2025 EPS estimates for Quince Therapeutics in a report issued on Tuesday, May 13th. Brookline Capital Management analyst K. Raja now expects that the company will post earnings per share of ($0.29) for the quarter, down from their prior estimate of […]
Quince Therapeutics, Inc. (NASDAQ:QNCX – Free Report) – Brookline Capital Management lowered their Q2 2025 EPS estimates for Quince Therapeutics in a report issued on Tuesday, May 13th. Brookline Capital Management analyst K. Raja now expects that the company will post earnings per share of ($0.29) for the quarter, down from their prior estimate of […]
